
PRCT
PROCEPT BioRobotics Corporation
$27.45
-$1.55(-5.34%)
50
Overall
55
Value
30
Tech
65
Quality
Market Cap
$1.85B
Volume
1.45M
52W Range
$19.35 - $66.85
Target Price
$30.44
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | $34.5M | $75.0M | $136.2M | $224.5M | $308.1M | ||
| Total Revenue | $34.5M | $75.0M | $136.2M | $224.5M | $308.1M | ||
| COST OF GOODS SOLD | |||||||
| Cost of Revenue | $18.6M | $37.9M | $65.1M | $87.4M | $111.8M | ||
| GROSS PROFIT | |||||||
| Gross Profit | $15.9M | $37.1M | $71.0M | $137.1M | $196.2M | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $70.0M | $117.8M | $180.2M | $233.7M | $300.1M | ||
| Research & Development | $19.0M | $29.0M | $48.4M | $62.3M | $71.3M | ||
| Research Expense | $19.0M | $29.0M | $48.4M | $62.3M | $71.3M | ||
| Selling, General & Administrative | $69.6M | $88.8M | $131.8M | $171.4M | $228.8M | ||
| Selling & Marketing Expenses | $18.6M | $100.0K | $300.0K | $500.0K | -- | ||
| General & Administrative Expenses | $51.0M | $88.8M | $131.8M | $171.4M | $228.8M | ||
| Salaries & Wages | -- | $10.3M | -- | -- | -- | ||
| Amortization | $300.0K | $300.0K | $300.0K | $300.0K | -- | ||
| Other Operating Expenses | $-510.0K | $-783.0K | -- | -- | -- | ||
| OPERATING INCOME | |||||||
| Operating income | $-54.2M | $-80.7M | $-109.2M | $-96.6M | $-103.9M | ||
| EBITDA | $-50.8M | $-82.0M | $-98.1M | $-81.6M | $-85.4M | ||
| NON-OPERATING ITEMS | |||||||
| Interest Expense (Non-Operating) | $5.8M | $5.2M | $4.0M | $4.2M | $3.6M | ||
| Intinc | $76.0K | $2.5M | $7.6M | $10.9M | $12.2M | ||
| Net Non-Operating Interest Income/Expense | $-5.8M | $2.7M | $7.6M | $-4.2M | $-3.6M | ||
| Gain on Sale of Securities | $135.0K | $-283.0K | $-107.0K | $-114.0K | -- | ||
| Other Income/Expense | $-199.0K | $-3.7M | $107.0K | $1.1M | $156.0K | ||
| Other Special Charges | $64.0K | $-3.3M | $-176.0K | $-1.0M | $-156.0K | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-54.2M | $-82.0M | $-101.9M | $-86.9M | $-91.8M | ||
| Pre-Tax Income | $-60.0M | $-87.2M | $-113.2M | $-91.0M | $-95.4M | ||
| INCOME TAX | |||||||
| Tax Provision | -- | -- | -- | $368.0K | $190.0K | ||
| NET INCOME | |||||||
| Net Income | $-59.9M | $-87.2M | $-105.9M | $-91.4M | $-95.6M | ||
| Net Income (Continuing Operations) | $-59.9M | $-87.2M | $-105.9M | $-91.4M | $-95.6M | ||
| Net Income (Discontinued Operations) | $-59.9M | $-87.2M | $-105.9M | $-91.4M | $-95.6M | ||
| Net Income (Common Stockholders) | $-59.9M | $-87.2M | $-105.9M | $-91.4M | $-95.6M | ||
| Normalized Income | -- | -- | -- | -- | $-94.4M | ||
| TOTALS | |||||||
| Total Expenses | $88.6M | $155.7M | $245.4M | $321.1M | $411.9M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $16.5M | $44.4M | $47.3M | $52.1M | $55.5M | ||
| Average Shares Outstanding (Diluted) | $16.5M | $44.4M | $47.3M | $52.1M | $55.5M | ||
| Shares Outstanding | $44.0M | $44.9M | $51.0M | $54.8M | $56.4M | ||
| Basic EPS | $-3.63 | $-1.96 | $-2.24 | $-1.75 | $-1.72 | ||
| Basic EPS (Continuing Operations) | $-3.63 | $-1.96 | $-2.24 | $-1.75 | $-1.72 | ||
| Diluted EPS | $-3.63 | $-1.96 | $-2.24 | $-1.75 | $-1.72 | ||
| Diluted EPS (Continuing Operations) | $-3.63 | $-1.96 | $-2.24 | $-1.75 | $-1.72 | ||
| OTHER METRICS | |||||||
| Commission Expenses | $18.6M | -- | -- | -- | -- | ||
| Marketing Expense | $18.6M | $100.0K | -- | -- | -- | ||
| Net Income From Other Gains Losses | $121.0K | -- | -- | -- | -- | ||
| Other Gand A | $51.0M | $88.8M | $131.8M | $171.4M | $228.8M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRCT | $27.45 | -5.3% | 1.45M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get PROCEPT BioRobotics Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW